When was Sevaro founded?

Sevaro was founded in 2013 and raised its 1st funding round 10 years after it was founded.

Where is Sevaro located?

Sevaro is headquartered in Philadelphia, United States.

How many employees does Sevaro have?

As of May 31, 2026, the latest employee count at Sevaro is 147.

Is Sevaro a funded company?

Sevaro is a funded company, having raised a total of $50M across 2 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Feb 28, 2023.

When was the latest funding round of Sevaro?

Sevaro's latest funding was a $***** Series B round on Jun 11, 2025, with participation from 2 investors.

Where does Sevaro rank among its competitors?

Sevaro ranks 2nd amongst 57 active competitors, of which 11 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Medical Brain, which secured $20M in Jun, 2025.

Who are the top competitors of Sevaro?

Sevaro's top competitors include Rune Labs, BIOS and Aleva Neuro. Among them, Medical Brain secured the most recent funding round in June, 2025.

Sevaro - 2026 Company Profile, Funding & Competitors

Company Details

Provider of telemedicine and consulting services for the healthcare sector. The telemedicine company provides custom teleneurology programs that improve patient outcomes. It offers OneCall, which is an intelligent communication system that improves emergent neurological care.

Website: sevaro.com
Social
Email ID: *****@sevaro.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

Philadelphia, United States

Stage

Series B

Total Funding

$50M in 2 rounds

Latest Funding Round

Series B, Jun 11, 2025, $*****

Investors

Intermountain Healthcare & 3 more

Ranked

2^nd among 57 active competitors

Employee Count

147 as on May 31, 2026

Similar Companies

Rune Labs & 25 more

View Sevaro's full profile

Sevaro is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sevaro Health Inc CIN: 830880277 , United States, Active	Dec 31, 2012	-	28 (As on Dec 31, 2024)	-

Sevaro has raised a total funding of $50M over 2 rounds. Its first funding round was on Feb 28, 2023. Its latest funding round was a Series B round on Jun 11, 2025 for $*****. 2 investors participated in its latest round. Sevaro has 4 institutional investors.

Here is the list of recent funding rounds of Sevaro:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 11, 2025	7559377	Series B	2772034	5846296	3619996	1616667
Feb 28, 2023	1247848	Series B	9692321	2968237	2932385	7541743

Access funding benchmarks and valuations. Sign up today!

View details of Sevaro's funding rounds and investors

Sevaro's employee count trend

Sevaro has 147 employees as of May 26. Here is Sevaro's employee count trend over the years:

Uncover Sevaro's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sevaro include Rune Labs, BIOS and Aleva Neuro. Here is the list of Top 10 competitors of Sevaro, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rune Labs 2018, San Francisco (United States), Series B	Platform provider for managing therapies	$56.5M	Eclipse, DigiTx Partners & 7 others	62/100
2nd	Sevaro 2013, Philadelphia (United States), Series B	Provider of telemedicine and consulting services for the healthcare sector	$50M	Catalyst Investors, Intermountain Healthcare ... & 2 others	50/100
3rd	BIOS 2015, Cambridge (United Kingdom), Series A	Developer of neural interfaces and AI for neural data analysis	$26M	AME Cloud Ventures, Real Ventures & 18 others	50/100
4th	Aleva Neuro 2008, Lausanne (Switzerland), Series E	Develops implantable deep brain stimulation systems that enables therapies for neurological diseases	$57M	CIP Merchant Capital, Venture Kick & 11 others	47/100
5th	Combinostics 2014, Finland, Acquired	AI-powered solutions for the detection and management of neurological disorders	$4.3M	Industrifonden, NordicNinja & 4 others	43/100
6th	Medical Brain 2017, New York City (United States), Series B	AI-based clinical decision support platform for neurological conditions	$25.9M	-	39/100
7th	IntraNerve Neuroscience 2007, Colorado Springs (United States), Unfunded	Provider of neurological therapy plan solutions for healthcare organizations	-	-	36/100
8th	Neurobrave 2018, Be er Sheva (Israel), Seed	Cloud-based neurology disease detection tool for healthcare professionals	-	Italian Angels for Growth, VentureIsrael & 2 others	34/100
9th	Nile 2017, Sherman Oaks (United States), Series B	Provider of AI-based epilepsy management tools for patients and providers	$29.3M	UCB	34/100
10th	Eyszlab 2018, United States, Funding Raised	Provider of software for the detection of epilepsy seizure	-	UCSF Rosenman Institute, Celtic House Asia Partners ... & 4 others	33/100